JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 8, 2007
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
282/23/16754    most recent
M701996200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ivanisevic, L.
Right arrow Articles by Saragovi, H. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivanisevic, L.
Right arrow Articles by Saragovi, H. U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print April 17, 2007
J. Biol. Chem, 10.1074/jbc.M701996200
Submitted on March 7, 2007
Revised on April 17, 2007
Accepted on April 17, 2007

TrkA receptor "hot spots" for binding of NT-3 as a heterologous ligand

Ljubica Ivanisevic, WenHua Zheng, Sang B. Woo, Kenneth E. Neet, and H. Uri Saragovi

Pharmacology & Therapeutics/Oncology, McGill University, Montreal, Quebec H3T 1E2

Corresponding Author: Uri.Saragovi{at}mcgill.ca

Neurotrophins signal via Trk tyrosine kinase receptors. NGF is the cognate ligand for TrkA, BDNF for TrkB, and NT-3 for TrkC. NT-3 also binds TrkA as a lower affinity heterologous ligand. Because NT-3 interactions with TrkA are biologically relevant, we aimed to define the TrkA “hot spot” functional docking sites of NT-3. The Trk extracellular domain consists of two cysteine rich subdomains (D1 and D3), flanking a leucine rich subdomain (D2), and two immunoglobulin-like subdomains IgC1 (D4) and IgC2 (D5). Previously, the D5 subdomain was defined as the primary ligand binding site of neurotrophins for their cognate receptors (e.g. NGF binds and activates through TrkA-D5 hot spots). Here, binding studies with truncated and chimeric extracellular subdomains show that TrkA-D5 also comprises an NT-3 docking and activation “hot spot” (site 1), and competition studies show that the NGF and NT-3 ”hot spots“ on TrkA-D5 are distinct but partially overlapping. In addition, ligand binding studies provide evidence for an NT-3 binding/allosteric site on TrkA-D4 (site 2). NT-3 docking on sites 1 and/or 2 partially blocks NGF binding. Functional survival studies showed that sites 1 and 2 regulate TrkA activation. NT-3 docking on both sites 1 and 2 affords full agonism, which can be additive with NGF activation of Trk. However, NT-3 docking solely on site 1 is partially agonistic, but non-competitively antagonizes NGF binding and activation of Trk. This study demonstrates that Trk signaling is more complex than previously thought because it involves several receptor subdomains and ”hot spots”.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. M. Mercader, E. Saus, Z. Aguera, M. Bayes, C. Boni, A. Carreras, E. Cellini, R. de Cid, M. Dierssen, G. Escaramis, et al.
Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders
Hum. Mol. Genet., May 1, 2008; 17(9): 1234 - 1244.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.